# GlaxoSmithKline Pharmaceuticals Limited (GLAXO.NS): MoatMap facts

As of 17 Oct 2026. Research data, not investment advice.

As of 17 Oct 2026, MoatMap's StockRank for GlaxoSmithKline Pharmaceuticals Limited (GLAXO.NS) is 83/100, ranked against 24,000+ stocks in 35 markets (Quality 87, Value 25, Momentum 67, each scored against its sector).

- StockRank: 83/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 87, Value 25, Momentum 67: each a 0-100 percentile within the stock's sector.
- Position: #4,665 overall, #530 in Healthcare.
- Listing: India, NSI; Healthcare / Drug Manufacturers - General.
- Last close: 2,524.7 INR on 15 Oct 2026.
- Insider filings, last 180 days: no director or 5%+ holder trades with a stated value.

Source: https://moatmap.ai/stock/GLAXO.NS
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker